Asset Dedication LLC Sells 3,275 Shares of International Business ...
π Asset Dedication LLC sold 3,275 shares of IBM in Q1, reducing its holding by 17.8% to a remaining value of $3.67 million.
π Norges Bank initiated a new position in IBM worth approximately $2.45 billion during the fourth quarter.
π Capital World Investors increased its stake by 29.2%, now owning over 22 million shares valued at $6.52 billion.
π Price T Rowe Associates Inc. MD raised its stake by 83.4% to own 5.6 million shares worth $1.66 billion.
π Corient Private Wealth LLC boosted its holdings by 359.6%, acquiring an additional 1.48 million shares.
π Vanguard Group Inc. grew its stake by 1.5% to own over 97 million shares worth $28.8 billion.
π Wolfe Research downgraded IBM to a 'peer perform' rating in a report dated June 23rd.
π Oppenheimer downgraded IBM from 'outperform' to 'market perform' in a July 15th research report.
π Bank of America raised its price target on IBM from $315.00 to $330.00 and maintained a 'buy' rating.
βοΈ IBM reported Q2 EPS of $2.93, which met analyst consensus estimates exactly.
π IBM revenue for the quarter was $17.16 billion, missing the analyst consensus estimate of $17.46 billion.
π° The company announced a quarterly dividend of $1.69 per share with an ex-dividend date of August 10th.
π IBM currently trades at a P/E ratio of 19.91 and has a market capitalization of $211.41 billion.
π The stock opened at $224.39, trading below its fifty-day moving average of $261.71.
π¦ Approximately 58.96% of IBM's outstanding stock is currently owned by hedge funds and institutional investors.
- Major institutional investors including Norges Bank, Capital World Investors, Price T Rowe Associates, Corient Private Wealth, and Vanguard Group all increased their stakes in the fourth quarter.
- Bank of America raised its price target to $330.00 and issued a 'buy' rating on IBM.
- IBM reported earnings per share of $2.93 which exactly met analyst consensus estimates.
- The company maintains a strong return on equity of 35.65% and a net margin of 15.52%.
- Needham & Company initiated coverage with a 'buy' rating for the technology giant.
- Wolfe Research downgraded IBM to a 'peer perform' rating, signaling caution on current valuation or growth prospects.
- Oppenheimer downgraded the stock from an 'outperform' rating to a 'market perform' rating.
- IBM's quarterly revenue of $17.16 billion missed analyst consensus estimates by approximately $300 million.
- The company's quick ratio is 0.74 and current ratio is 0.79, indicating liquidity levels below 1.0.
- Wolfe Research's downgrade suggests potential concerns regarding the company's competitive positioning or profitability trajectory.